Issue 3, 2012

Antimalarialperoxides: advances in drug discovery and design

Abstract

Cyclic peroxides such as the plant-derived 1,2,4-trioxane artemisinin and its derivatives are short-lived, rapidly-acting antimalarials that are now usually combined with standard long-lived, alkaloidal antimalarials; such artemisinin combination therapy (ACT) is the worldwide standard operating procedure for malaria chemotherapy. This review discusses antimalarial monomeric and dimeric derivatives of artemisinin, peroxides not derived from artemisinin, and finally hybrids containing one peroxide unit covalently linked to a non-peroxide unit. Emphasis is placed on the antimalarial effectiveness of these diverse cyclic peroxides and on the simplicity of their synthesis.

Graphical abstract: Antimalarial peroxides: advances in drug discovery and design

Article information

Article type
Review Article
Submitted
02 Nov 2011
Accepted
06 Dec 2011
First published
07 Dec 2011

Med. Chem. Commun., 2012,3, 281-297

Antimalarial peroxides: advances in drug discovery and design

R. D. Slack, A. M. Jacobine and G. H. Posner, Med. Chem. Commun., 2012, 3, 281 DOI: 10.1039/C2MD00277A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements